4.6 Article

Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS - Neurofilament as a Surrogate of Disease Progression

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Impact of Inflammation on Brain Volume in Multiple Sclerosis

Jojy Cheriyan et al.

ARCHIVES OF NEUROLOGY (2012)

Article Geriatrics & Gerontology

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers

Maartje I. Kester et al.

NEUROBIOLOGY OF AGING (2012)

Article Clinical Neurology

Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter

Marco Vercellino et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)

Article Clinical Neurology

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

C. E. Teunissen et al.

NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury

G Shaw et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Article Clinical Neurology

Acute axonal damage predicts clinical outcome in patients with multiple sclerosis

ET Lim et al.

MULTIPLE SCLEROSIS JOURNAL (2005)

Article Clinical Neurology

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study

A Petzold et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Article Immunology

Plasma osteopontin levels in multiple sclerosis

M Comabella et al.

JOURNAL OF NEUROIMMUNOLOGY (2005)

Article Biochemical Research Methods

An ELISA for glial fibrillary acidic protein

A Petzold et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2004)

Article Clinical Neurology

Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis

A Petzold et al.

MULTIPLE SCLEROSIS JOURNAL (2004)